Literature DB >> 31161653

Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis.

Kamil M Amer1, Jennifer E Thomson, Dominick Congiusta1, Andrew Dobitsch1, Ahmed Chaudhry1, Matthew Li2, Aisha Chaudhry1, Anthony Bozzo3, Brianna Siracuse1, Mahmut Nedim Aytekin4, Michelle Ghert5, Kathleen S Beebe1.   

Abstract

Rhabdomyosarcoma is the most common soft-tissue sarcoma in children and adolescents and accounts for 3% of all pediatric tumors. Subtypes include alveolar, spindle cell, embryonal, mixed-type, pleomorphic, and rhabdomyosarcoma with ganglionic differentiation. The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database was queried for patients diagnosed with any type of rhabdomyosarcoma between 1973 and 2014. Patient demographics, tumor characteristics, and incidence were studied with χ2 analysis. Survival was modeled with Kaplan-Meier survival curves and Cox proportional hazards models were used to assess the effect of age and gender on survival. Pleomorphic subtype had higher grade and larger sized tumors compared to other subtypes (p < 0.05). Pleomorphic and alveolar rhabdomyosarcoma had the worst overall survival with a 26.6% and 28.9% 5-year survival, respectively. Embryonal rhabdomyosarcoma had the highest 5-year survival rate (73.9%). Tumor size was negatively correlated with survival months, indicating patients with larger tumors had shorter survival times (p < 0.05). Presence of higher-grade tumors and metastatic disease at presentation were negatively correlated with survival months (p < 0.05). No significant differences in the survival were found between gender or race between all of the subtypes (p > 0.05). This study highlights key differences in the demographic and survival rates of the different types of rhabdomyosarcoma that can be used for more tailored patient counseling. We also demonstrate that large, population-level databases provide sufficient data that can be used in the analysis of rare tumors.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:2226-2230, 2019. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  Chondrosarcoma; SEER; cancer/tumors; epidemiology; statistics

Mesh:

Year:  2019        PMID: 31161653     DOI: 10.1002/jor.24387

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  26 in total

1.  Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).

Authors:  Kirk D Wyatt; Suzi Birz; Douglas S Hawkins; Veronique Minard-Colin; David A Rodeberg; Monika Sparber-Sauer; Gianni Bisogno; Ewa Koscielniak; Gian Luca De Salvo; Martin Ebinger; Johannes H M Merks; Suzanne L Wolden; Wei Xue; Samuel L Volchenboum
Journal:  Pediatr Blood Cancer       Date:  2022-08-15       Impact factor: 3.838

2.  Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.

Authors:  Ritesh K Srivastava; Purushotham Guroji; Lin Jin; M Shahid Mukhtar; Mohammad Athar
Journal:  Mol Carcinog       Date:  2022-04-26       Impact factor: 5.139

3.  An Exceptionally Rare Primary Epithelioid Rhabdomyosarcomas of the Stomach: A Case Report.

Authors:  Lav Kumar Shah; Nashruva Jahan Mony; Sumitanand Mishra; Biswas Pant
Journal:  Cureus       Date:  2022-06-17

4.  Prognostic Factors in Patients with Rhabdomyosarcoma Using Competing-Risks Analysis: A Study of Cases in the SEER Database.

Authors:  Didi Han; Chengzhuo Li; Xiang Li; Qiao Huang; Fengshuo Xu; Shuai Zheng; Hui Wang; Jun Lyu
Journal:  J Oncol       Date:  2020-09-17       Impact factor: 4.375

5.  Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis.

Authors:  Wei-Qiang Tang; Yan Hei; Jing Lin
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

6.  Radiation therapy is an important factor to improve survival in pediatric patients with head and neck rhabdomyosarcoma by enhancing local control: a historical cohort study from a single center.

Authors:  Yuan Wen; Dongsheng Huang; Weiling Zhang; Yi Zhang; Huimin Hu; Jing Li
Journal:  BMC Pediatr       Date:  2020-05-29       Impact factor: 2.125

7.  Characteristics and prognosis of embryonal rhabdomyosarcoma in children and adolescents: An analysis of 464 cases from the SEER database.

Authors:  Xinyu Wang; Jun Feng; Zhe Li; Xin Zhang; Jun Chen; Guoshuang Feng
Journal:  Pediatr Investig       Date:  2020-12-28

8.  Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.

Authors:  Sabine Schleicher; Stefan Grote; Elke Malenke; Kenneth Chun-Ho Chan; Martin Schaller; Birgit Fehrenbacher; Rosa Riester; Torsten Kluba; Leonie Frauenfeld; Hans Boesmueller; Gudrun Göhring; Brigitte Schlegelberger; Rupert Handgretinger; Hans-Georg Kopp; Frank Traub; Karen A Boehme
Journal:  Cells       Date:  2020-12-11       Impact factor: 6.600

9.  Pitfalls in diagnosing orbital malignancy through orbital incisional biopsy: A report of two cases with different scenarios.

Authors:  Hind M Alkatan; Khaled A Helmi; Azza M Y Maktabi
Journal:  Saudi J Ophthalmol       Date:  2021-02-27

10.  Alveolar rhabdomyosarcoma with unusual cytogenetic findings: one more case and review of the literature.

Authors:  Maria Ioannou; Konstantinos Perivoliotis; Nikolaos-Marios Zaharos; Athanasios Tsanakas; Konstantinos Tepetes; George Koukoulis
Journal:  Oxf Med Case Reports       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.